Coventry

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis1 trial
• HIV1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• GlaxoSmithKline2 trials
• ViiV Healthcare1 trial

Running trials

• Recruiting

  A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

  NCT07201051· Phase 2· GlaxoSmithKline· Source

  Contact: Beatriz Lara Gallego (principal investigator)

• Active, not recruiting

  Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

  NCT04915755· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

  NCT02938520· Phase 3· ViiV Healthcare· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bronchiectasis1 recruiting